BLUEBIRD ENERGY PLC

(AIM: BBE)


Directorate Changes


Bluebird Energy plc ("Bluebird" or "the Company") is pleased to announce the appointment of Gordon Hall to the Board as an independent non-executive director with immediate effect.


Gordon is a non-executive director of Nanoco Group Plc and EKF Diagnostics plc. After an early career in teaching, Gordon built up substantial international sales, management and development expertise with Rank Xerox and Abbott Laboratories. He became Chief Executive Officer of Shield Diagnostic Ltd (now Axis Shield plc) in 1990 and was responsible for listing the company on the London Stock Exchange.


The Company also announces that Andy Yeo and Frederik Dekker have resigned from the Board as CEO and non-executive director, respectively, with immediate effect to focus on their other executive responsibilities. James Ede-Golightly will assume executive responsibilities on an interim basis.


Commenting on today's announcement, James Ede-Golightly, Chairman of Bluebird, said:

"On behalf of the Board, I would like to welcome Gordon to Bluebird. I would also thank Andy and Frederik for their contribution to the company."


Gordon James Hall(aged 70)


Directorships in the last five years are as follows:


Name

Further Detail

EKF Diagnostics Holdings Plc


Nanoco Group Plc


Nanoco Life Science Limited


Osmetech Limited

Resigned 31/12/2008

Plectrum Petroleum Limited

Resigned 10/10/2007

Nanoco Tech Limited

Resigned 12/10/2010

Tissue Regenix Group Plc

Resigned 26/06/2010


There are no other disclosures required in accordance with Schedule 2(g) of the AIM Rules.


Contacts


Bluebird Energy plc

www.bluebirdenergy.net

James Ede-Golightly

+44 (0)
1225 428139



WH Ireland Limited

www.wh-ireland.co.uk

John Wakefield/Marc Davies

+44 (0) 117 945 3470




This information is provided by RNS
The company news service from the London Stock Exchange
ENDBOALLFVEAVIDFIF
distributed by